2026
Acute Seizures and Aphasia in a Patient With Suspected Systemic Lupus Erythematosus: A Diagnostic Puzzle Unveiling Diffuse Hemispheric Glioma, H3 G34-Mutant.
Cureus
PubMed • Publisher's siteHans H Shuhaiber, MD
Neurologist
Rated
4.3
out of 5 stars
- Additional languages:
- Spanish,
- French
Research at a glance
Top areas of exploration
- Neurofibroma, Plexiform , 2 publications
- Neurofibromatosis 1 , 2 publications
- Birth Injuries , 2 publications
- Brachial Plexus Neuropathies , 2 publications
Research activity
Focus
\industry-sponsored clinical trials to help patients with complex pain issues caused by Plexiform neurofibroma. Please send me an email at hshuhaiber@ufl.edu to evaluate your eligibility for a clinical trial. https://neurology.ufl.edu/divisions/neurofibromatosis-center/neurofibromatosis-clinical-trials/ https://neurology.ufl.edu/wordpress/files/2025/06/GS4302-273774-USA-Physician-Infogetter-20240821-1.0-English.pdf
My publications
Filter publications
25 publications
2026
Update from the Long-Term Follow-Up Phase of ReNeu: A Pivotal Phase 2b Trial of Mirdametinib in Adults and Children with Neurofibromatosis Type 1-Associated Symptomatic Plexiform Neurofibroma
Neuropediatrics
Publisher's site2025
CTNI-06. UPDATE FROM THE LONG-TERM FOLLOW-UP (LTFU) PHASE OF RENEU: A PIVOTAL PHASE 2B TRIAL OF MIRDAMETINIB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1)-ASSOCIATED SYMPTOMATIC PLEXIFORM NEUROFIBROMA (PN)
Neuro-Oncology
Publisher's site2025
CTNI-55. EXPLORING THE RELATIONSHIP BETWEEN PATIENT BASELINE CHARACTERISTICS WITH RESPONSES TO MIRDAMETINIB IN THE RENEU TRIAL OF CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1)-ASSOCIATED PLEXIFORM NEUROFIBROMA (PN)
Neuro-Oncology
Publisher's site2025
OS04.4.A RENEU LONG-TERM FOLLOW-UP (LTFU) UPDATE: A PIVOTAL, PHASE 2B TRIAL OF MIRDAMETINIB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1)-ASSOCIATED SYMPTOMATIC PLEXIFORM NEUROFIBROMA (PN)
Neuro-Oncology
Publisher's site